Chemical formula: C₁₇H₁₉NO₃ Molecular mass: 285.338 g/mol PubChem compound: 5284570
Hydromorphone is an agonist of mu receptors. The pharmacological actions of hydromorphone and morphine do not differ significantly. Hydromorphone and related opioids produce their major effects on the central nervous system and bowel. Hydromorphone is indicated for the relief of severe pain in cancer.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02AA03 | Hydromorphone | N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DILAUDID Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| PALLADONE Prolonged release capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PALLADONE Solution for injection or infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Hydromorphone is an active ingredient of these brands:
Canada (CA)
Estonia (EE)
France (FR)
Germany (DE)Ireland (IE)Japan (JP)Netherlands (NL)
Singapore (SG)
South Africa (ZA)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
